Lymphopenia and leukopenia have been observed in patients with COVID-19, which can be due to increased expression of FAS and FAS-L in T-cells, B-cells, and NK cells and as a result of increased apoptosis in these cells. This evidence concerns the gene FAS and lymphopenia.